165 related articles for article (PubMed ID: 22232350)
1. Association of sequence alterations in the putative promoter of RAB7L1 with a reduced parkinson disease risk.
Gan-Or Z; Bar-Shira A; Dahary D; Mirelman A; Kedmi M; Gurevich T; Giladi N; Orr-Urtreger A
Arch Neurol; 2012 Jan; 69(1):105-10. PubMed ID: 22232350
[TBL] [Abstract][Full Text] [Related]
2. RAB7L1 promoter polymorphism and risk of Parkinson's disease; a case-control study.
Khaligh A; Goudarzian M; Moslem A; Mehrtash A; Jamshidi J; Darvish H; Emamalizadeh B
Neurol Res; 2017 May; 39(5):468-471. PubMed ID: 28245721
[TBL] [Abstract][Full Text] [Related]
3. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
[TBL] [Abstract][Full Text] [Related]
4. Fine mapping and resequencing of the PARK16 locus in Parkinson's disease.
Pihlstrøm L; Rengmark A; Bjørnarå KA; Dizdar N; Fardell C; Forsgren L; Holmberg B; Larsen JP; Linder J; Nissbrandt H; Tysnes OB; Dietrichs E; Toft M
J Hum Genet; 2015 Jul; 60(7):357-62. PubMed ID: 25855069
[TBL] [Abstract][Full Text] [Related]
5. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
[TBL] [Abstract][Full Text] [Related]
6. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.
MacLeod DA; Rhinn H; Kuwahara T; Zolin A; Di Paolo G; McCabe BD; Marder KS; Honig LS; Clark LN; Small SA; Abeliovich A
Neuron; 2013 Feb; 77(3):425-39. PubMed ID: 23395371
[TBL] [Abstract][Full Text] [Related]
7. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Gan-Or Z; Giladi N; Rozovski U; Shifrin C; Rosner S; Gurevich T; Bar-Shira A; Orr-Urtreger A
Neurology; 2008 Jun; 70(24):2277-83. PubMed ID: 18434642
[TBL] [Abstract][Full Text] [Related]
8. An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in China.
Guo XY; Chen YP; Song W; Zhao B; Cao B; Wei QQ; Ou RW; Yang Y; Yuan LX; Shang HF
Eur J Neurol; 2014 Oct; 21(10):1337-43. PubMed ID: 25040112
[TBL] [Abstract][Full Text] [Related]
9. Genetic variants in the RAB7L1 and SLC41A1 genes of the PARK16 locus in Chinese Parkinson's disease patients.
Yan Y; Tian J; Mo X; Zhao G; Yin X; Pu J; Zhang B
Int J Neurosci; 2011 Nov; 121(11):632-6. PubMed ID: 21812739
[TBL] [Abstract][Full Text] [Related]
10. The rs1572931 polymorphism of the RAB7L1 gene promoter is associated with reduced risk of Parkinson's disease.
Goudarzian M; Khaligh A; Fourozan R; Jamal Mirmoosavi S; Darvish H; Safaralizadeh T; Emamalizadeh B
Neurol Res; 2015 Nov; 37(11):1029-31. PubMed ID: 26344175
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
[TBL] [Abstract][Full Text] [Related]
12. Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.
Wu-Chou YH; Chen YT; Yeh TH; Chang HC; Weng YH; Lai SC; Huang CL; Chen RS; Huang YZ; Chen CC; Hung J; Chuang WL; Lin WY; Chen CH; Lu CS
Parkinsonism Relat Disord; 2013 Feb; 19(2):251-5. PubMed ID: 23182315
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population.
Liu X; Cheng R; Verbitsky M; Kisselev S; Browne A; Mejia-Sanatana H; Louis ED; Cote LJ; Andrews H; Waters C; Ford B; Frucht S; Fahn S; Marder K; Clark LN; Lee JH
BMC Med Genet; 2011 Aug; 12():104. PubMed ID: 21812969
[TBL] [Abstract][Full Text] [Related]
14. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
[TBL] [Abstract][Full Text] [Related]
15. LRRK2 Gly2385Arg polymorphism, cigarette smoking, and risk of sporadic Parkinson's disease: a case-control study in Japan.
Miyake Y; Tsuboi Y; Koyanagi M; Fujimoto T; Shirasawa S; Kiyohara C; Tanaka K; Fukushima W; Sasaki S; Yamada T; Oeda T; Miki T; Kawamura N; Sakae N; Fukuyama H; Hirota Y; Nagai M;
J Neurol Sci; 2010 Oct; 297(1-2):15-8. PubMed ID: 20673920
[TBL] [Abstract][Full Text] [Related]
16. The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation. Association with Parkinson disease, malignant melanoma and prevalence in ethnic groups in Israel.
Hassin-Baer S; Laitman Y; Azizi E; Molchadski I; Galore-Haskel G; Barak F; Cohen OS; Friedman E
J Neurol; 2009 Mar; 256(3):483-7. PubMed ID: 19412725
[TBL] [Abstract][Full Text] [Related]
17. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
Tan EK; Kwok HH; Tan LC; Zhao WT; Prakash KM; Au WL; Pavanni R; Ng YY; Satake W; Zhao Y; Toda T; Liu JJ
Neurology; 2010 Aug; 75(6):508-12. PubMed ID: 20697102
[TBL] [Abstract][Full Text] [Related]
18. The LRRK2 G2385R variant is a risk factor for sporadic Parkinson's disease in the Korean population.
Kim JM; Lee JY; Kim HJ; Kim JS; Shin ES; Cho JH; Park SS; Jeon BS
Parkinsonism Relat Disord; 2010 Feb; 16(2):85-8. PubMed ID: 19854095
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor (BDNF) genetic polymorphism greatly increases risk of leucine-rich repeat kinase 2 (LRRK2) for Parkinson's disease.
Liu J; Zhou Y; Wang C; Wang T; Zheng Z; Chan P
Parkinsonism Relat Disord; 2012 Feb; 18(2):140-3. PubMed ID: 21924942
[TBL] [Abstract][Full Text] [Related]
20. Parkinson's disease-associated mutant LRRK2 phosphorylates Rab7L1 and modifies trans-Golgi morphology.
Fujimoto T; Kuwahara T; Eguchi T; Sakurai M; Komori T; Iwatsubo T
Biochem Biophys Res Commun; 2018 Jan; 495(2):1708-1715. PubMed ID: 29223392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
